Police Seizures of Psilocybin Are Soaring Throughout U.S.
NYU Langone study finds that law-enforcement seizures of psilocybin have jumped 369 percent since 2017, suggesting drug may be easier to access.
Psilocybin Therapy May Address Mental Health Concerns
NYU Langone study shows that psilocybin therapy may improve mental health in cancer patients and patients with alcohol use disorder.
Hallucinogenic Drug Helps Patients with Advanced Cancer
NYU Langone study finds the hallucinogenic drug psilocybin, when combined with counseling, relieves depression and anxiety in cancer patients.
Psychedelic Drug Therapy May Help Treat Alcohol Addiction
NYU Langone study shows that 2 doses of psilocybin combined with psychotherapy reduces alcohol consumption by 83 percent among heavy drinkers.
Psychedelic Drug Benefits Persist in People with Cancer
NYU Langone study finds a psychedelic drug improved emotional distress in people with cancer for nearly five years after treatment.
Novel Therapeutic Agents for Hard-to-Treat Mental Conditions
NYU Langone’s Dr. Michael P. Bogenschutz, Dr. Stephen Ross, and colleagues explore therapeutic agents such as psilocybin, cannabidiol, and MDMA.
Podcast: Rethinking the Role of Psychedelics in Medicine
NYU Langone psychiatrist Dr. Stephen Ross sees potential for psychedelic drugs to treat anxiety, depression, and other mental health disorders.
NYU Langone Health in the News— Wednesday, June 11, 2025
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from June 11, 2025.
NYU Langone Health in the News—January 7, 2025
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from January 7, 2025.
NYU Langone Health in the News—January 21, 2025
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from January 21, 2025.